Skip to content

Clinical trials

Completed Phase 2 Rheumatic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Phase: Phase 2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20132
20151
20161
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Amgen1
Bioxtract SA1
Cara Therapeutics, Inc.1
Lakefront Biotherapeutics NV1
Levicept1
Olatec Therapeutics, Inc.1
Pfizer1
Syntrix Biosystems, Inc.1
University of Alabama at Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases10
Arthritis8
Joint Diseases8
Musculoskeletal Diseases7
Osteoarthritis5
Arthritis, Rheumatoid4
Autoimmune Diseases4
Osteoarthritis, Knee4
Connective Tissue Diseases2
Pain2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.